Suppr超能文献

门诊护理环境中成人癌症患者接受治疗性患者教育对口服抗癌药物依从性的有效性:一项系统综述

The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.

作者信息

Arthurs Gilly, Simpson Janice, Brown Andrea, Kyaw Ohnma, Shyrier Sharon, Concert Catherine M

机构信息

College of Health Professions, Pace University, New York, United States of America.

The Northeast Institute for Evidence Synthesis and Translation (NEST): a Collaborating Centre of the Joanna Briggs Institute; Lienhard School of Nursing, Pace University, New York, United States of America.

出版信息

JBI Database System Rev Implement Rep. 2015 Jun 12;13(5):244-92. doi: 10.11124/jbisrir-2015-2057.

Abstract

BACKGROUND

Adherence to oral cancer medicines is a challenge for adult patients with cancer. Education specifically tailored for an individual patient with cancer may improve adherence. Therapeutic patient education when utilized effectively may maximize health outcomes and positively affect the quality of life of adult patients with cancer. Currently, there are no published systematic reviews specific to the effectiveness of therapeutic patient education on improvement of oral anti-cancer medicines adherence in patients with cancer.

OBJECTIVES

To synthesize the best available evidence on the effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients 18 years and older in an ambulatory care setting.

INCLUSION CRITERIA

Types of participants: This review considered studies involving adults of any ethnicity, race or gender, aged 18 years or older who were diagnosed with any form of cancer, receiving oral anti-cancer medicines in an ambulatory care setting. Types of intervention(s): This review considered studies on the use of therapeutic patient education as the additional intervention to routine patient education for promoting oral anti-cancer medicine adherence in adult patients with cancer in an ambulatory care setting. Routine patient education was considered as a comparator. Types of outcomes: The outcome considered was adherence to prescribed oral anti-cancer medicines. Types of studies: This review considered experimental and observational studies.

SEARCH STRATEGY

The literature search included published and unpublished studies in the English Language from 1953 through August 2014. A search of PubMed, CINAHL, Excerpta Medica Database, Academic Search Premier, Cochrane Library, PsycINFO, and Health Source: Nursing/Academic Edition was conducted using identified keywords and indexed terms across all included databases. A search for grey literature and electronic hand searching of relevant journals was also performed.

METHODOLOGICAL QUALITY

Two reviewers independently evaluated the included studies for methodological quality utilizing standardized critical appraisal instruments from the Joanna Briggs Institute.

DATA COLLECTION

Standardized data extraction tools were used by two reviewers independently as per the Joanna Briggs Institute for data extraction.

DATA SYNTHESIS

Due to clinical and methodological heterogeneity between the included studies, statistical meta-analysis was not feasible. The results are presented in a narrative form.

RESULTS

Two studies were included in this review, one randomized controlled trial and one cohort study. Both studies had small sample sizes and were moderate and low quality. The clinical significance of therapeutic patient education interventions and the relationship between behavior changes and health outcome changes remain unclear. The randomized clinical trial found a benefit in medication adherence rates in the tailored education intervention group compared to the standard education group at two and four months. Adherence rates measured by self-report (91.3% and 95.1%) and pharmacy refill rates (80% and 73.7%) were superior for the intervention group; however pharmacy refill rates were lower than self-reports of adherence. Tailored educational interventions were only beneficial on pharmacy refill rates (p=.0048) for promoting adherence at the two-month time interval. The cohort study found the intensified pharmaceutical educational intervention group demonstrated enhanced overall medication adherence then the standard education group (97.9% vs. 90.5%, p=0.069). The intervention group also showed a higher mean daily adherence to medication (96. 8% vs. 87.2%, p=0.029). The relative risk of the intervention group deviating from the medication intake interval of 12 hours was 0.51(95%CI, 0.46-0.56) compared to the control group (p<0.05, Chi-square test).The two studies showed no statistically significant differences, only modest to low evidence that therapeutic educational interventions support the clinical outcome of oral anti-cancer medicine adherence.

CONCLUSIONS

There is a paucity of research evidence on the effectiveness of therapeutic patient educational interventions for improving patient adherence to oral cancer medicines. The effect of therapeutic patient educational interventions on oral anti-cancer medicine adherence has yet to be determined. Therapeutic patient educational interventions remain questionable, differing in format and educational strategies. A specific standardized methodology and evaluation approach to therapeutic patient education may reduce symptomatology, prevent side effects, maximize health outcomes and positively affect the quality of life and survival of adult patients with cancer.

IMPLICATIONS FOR PRACTICE

There is limited evidence that therapeutic patient educational interventions improve oral anti-cancer medicine adherence in adult patients with cancer in ambulatory care settings. A growing number of patients with cancer are being prescribed oral anti-cancer medicines; a better understanding of how therapeutic patient education strategies are effectively implemented may promote patient self-motivation and oral anti-cancer medicine adherence. This review recommends the development of a specific standardized methodology and evaluation approach to therapeutic patient education that may empower patients to increase their adherence to self-managed medication and achieve positive health outcomes

IMPLICATIONS FOR RESEARCH

Clinical trials with larger sample sizes, standardization of content, comparing specific adherence education or tailored education interventions are needed.

摘要

背景

坚持服用口服抗癌药物对成年癌症患者来说是一项挑战。为个体癌症患者量身定制的教育可能会提高依从性。有效利用治疗性患者教育可能会使健康结果最大化,并对成年癌症患者的生活质量产生积极影响。目前,尚无针对治疗性患者教育对提高癌症患者口服抗癌药物依从性有效性的系统评价发表。

目的

综合现有最佳证据,探讨治疗性患者教育对18岁及以上成年癌症患者在门诊环境中坚持口服抗癌药物的有效性。

纳入标准

参与者类型:本评价纳入了涉及任何种族、民族或性别的18岁及以上成年人的研究,这些人被诊断患有任何形式的癌症,在门诊环境中接受口服抗癌药物治疗。干预类型:本评价纳入了关于将治疗性患者教育作为常规患者教育的额外干预措施,以促进成年癌症患者在门诊环境中坚持口服抗癌药物治疗的研究。常规患者教育被视为对照。结局类型:考虑的结局是坚持服用规定的口服抗癌药物。研究类型:本评价纳入了实验性和观察性研究。

检索策略

文献检索包括1953年至2014年8月以英文发表和未发表的研究。使用确定的关键词和索引词在所有纳入数据库中对PubMed、CINAHL、医学文摘数据库、学术搜索全文数据库、Cochrane图书馆、PsycINFO和健康源:护理/学术版进行了检索。还进行了灰色文献检索和相关期刊的电子手工检索。

方法学质量

两名评价者使用乔安娜·布里格斯研究所的标准化批判性评价工具独立评估纳入研究的方法学质量。

数据收集

两名评价者根据乔安娜·布里格斯研究所的要求独立使用标准化数据提取工具进行数据提取。

数据综合

由于纳入研究之间存在临床和方法学异质性,无法进行统计荟萃分析。结果以叙述形式呈现。

结果

本评价纳入了两项研究,一项随机对照试验和一项队列研究。两项研究的样本量都较小,质量中等和较低。治疗性患者教育干预的临床意义以及行为改变与健康结局改变之间的关系仍不明确。随机临床试验发现,与标准教育组相比,定制教育干预组在两个月和四个月时的药物依从率有所提高。干预组通过自我报告测得的依从率(91.3%和95.1%)和药房配药率(80%和73.7%)更高;然而,药房配药率低于自我报告的依从率。定制教育干预仅在两个月的时间间隔内对药房配药率(p = 0.004)促进依从性方面有益。队列研究发现,强化药物教育干预组的总体药物依从性高于标准教育组(97.9%对90.5%,p = 0.069)。干预组的平均每日药物依从性也更高(96.8%对87.2%,p = 0.029)。与对照组相比,干预组偏离12小时服药间隔的相对风险为0.51(95%CI,0.46 - 0.56)(p < 0.05,卡方检验)。两项研究均未显示出统计学上的显著差异,仅有适度至低水平的证据表明治疗性教育干预支持口服抗癌药物依从性的临床结局。

结论

关于治疗性患者教育干预对提高患者口服抗癌药物依从性有效性的研究证据不足。治疗性患者教育干预对口服抗癌药物依从性的影响尚未确定。治疗性患者教育干预在形式和教育策略上存在差异,仍存在疑问。一种针对治疗性患者教育的特定标准化方法和评价方法可能会减轻症状学、预防副作用、使健康结局最大化,并对成年癌症患者的生活质量和生存率产生积极影响。

对实践的启示

在门诊环境中,治疗性患者教育干预改善成年癌症患者口服抗癌药物依从性的证据有限。越来越多的癌症患者正在服用口服抗癌药物;更好地理解如何有效实施治疗性患者教育策略可能会促进患者的自我激励和口服抗癌药物依从性。本评价建议制定一种针对治疗性患者教育的特定标准化方法和评价方法,这可能会使患者有能力提高其对自我管理药物的依从性并实现积极的健康结局。

对研究的启示

需要进行样本量更大、内容标准化、比较特定依从性教育或定制教育干预的临床试验。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验